0001622240-15-000002.txt : 20150508 0001622240-15-000002.hdr.sgml : 20150508 20150508163911 ACCESSION NUMBER: 0001622240-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150508 DATE AS OF CHANGE: 20150508 EFFECTIVENESS DATE: 20150508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Supreme Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001622240 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-239501 FILM NUMBER: 15847372 BUSINESS ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 BUSINESS PHONE: 604-674-2191 MAIL ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 D 1 primary_doc.xml X0707 D LIVE 0001622240 Supreme Pharmaceuticals Inc. 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 (416) 630-7272 BRITISH COLUMBIA, CANADA Supreme Resources Ltd. None Corporation true John Fowler 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Executive Officer Director President Peter Herburger 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Executive Officer Director of Operations Cailin Gehlsen 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Executive Officer Interim Chief Financial Officer Christopher Bechtel 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Director Allan Levien 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Director Pharmaceuticals Decline to Disclose 06b false 2015-04-23 false true true true false 0 Canaccord Genuity Corp. None None None 2200 - 609 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA V7Y 1H2 true Global Securities Corporation None None None 1100-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1C4 true George Callahan None None None #336 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 true Barbara Fisher None None None 402 Highland Drive Kincardine A6 ONTARIO, CANADA N2Z 1X3 true 1212649 1212649 0 Total offered and sold in the US is $534,831.26 USD. Remaining $677,817.65 USD were offered and sold outside of the US. Canadian dollars converted to US dollars at an exchange rate of CDN$1.00 = USD$0.8273 (Bank of Canada noon exchange rate on 5/8/15). false 27 41997 124 Canadian dollars converted to US dollars at an exchange rate of CDN$1.00 = USD$0.8273 (Bank of Canada noon exchange rate on 5/8/15). 0 false Supreme Pharmaceuticals Inc. /s/ John Fowler John Fowler President 2015-05-08